Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial-cell proliferation and acquired recurrence of middle-ear cholesteatoma

Laboratory Investigation

Volumn 83, Issue 1, 2003, Pages 123-136

  Yamamoto Fukuda, Tomomi ^a   Aoki, Daiyu ^a   Hishikawa, Yoshitaka ^a   Kobayashi, Toshimitsu ^b   Takahashi, Haruo ^a   Koji, Takehiko ^a,c  

^a Nagasaki University   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CYTOKERATIN; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN S 100; VIMENTIN;

ADULT; ARTICLE; CELL PROLIFERATION; CHOLESTEATOMA; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GRANULATION TISSUE; HUMAN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MESENCHYME CELL; MIDDLE EAR DISEASE; MIDDLE EAR TUMOR; MOLECULAR MECHANICS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RECURRENCE RISK; RNA ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0037245219     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000050763.64145.CB     Document Type: Article

References (76)

1. Adams JC (1981). Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29:775.
2. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, and Cunha GR (1994). Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci U S A 91:1074-1078.
3. Andreadis ST, Hamoen KE, Yarmush ML, and Morgan JR (2001). Keratinocyte growth factor induces hyperproliferation and delays differentiations in a skin equivalent model system. FASEB J 15:898-906.
4. Bagger-Sjoback D and Phelps PD (1985). Cholesteatoma with extension to the cochlea. Am J Otol 6:338-343.
5. Bajaj-Elliott M, Breese E, Poulsom R, Fairclough PD, and MacDonald TT (1997). Keratinocyte growth factor in inflammatory bowel disease. Increased mRNA transcripts in ulcerative colitis compared with Crohn's disease in biopsies and isolated mucosal myofibroblasts. Am J Pathol 151:1469-1476.
6. Barazzone C, Donati YR, Rochat AF, Vesin C, Kan CD, Pache JC, and Piguet PF (1999). Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am J Pathol 154:1479-1487.
7. Boismenu R and Havran WL (1994). Modulation of epithelial cell growth by intraepithelial γδT cells. Science 266:1253-1255.
8. Brauchle M, Angermeyer K, Hubner G, and Werner S (1994). Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 9:3199-3204.
9. Brauchle M, Madlener M, Wagner AD, Angermeyer K, Lauer U, Hofschneider PH, Gregor M, and Werner S (1996). Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am J Pathol 149:521-529.
10. Brunner T, Arnold D, Wasem C, Herren S, and Frutschi C (2001). Regulation of cell death and survival in intestinal intraepithelial lymphocytes. Cell Death Differ 8:706-714.
11. Bujia J, Kim C, Ostos P, Kastenbauer E, and Hultner L (1996). Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas. Eur Arch Otorhinolaryngol 253:152-157.
12. Cancilla B and Risbridger GP (1998). Differential localization of fibroblast growth factor receptor-1, -2, -3, and -4 in fetal, immature, and adult rat testes. Biol Reprod 58:1138-1145.
13. Cartun RW, Coles FB, and Pastuszak WT (1987). Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues. Am J Pathol 129:415-421.
14. Chedid M, Rubin JS, Csaky KG, and Aaronson SA (1994). Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem 269:10753-10757.
15. Chole RA (1992). Cholesteatoma: conference summary. In: Nakano Y, editor. Cholesteatoma and Mastoid Surgery Fourth International Conference, Niigata, Japan, September 8-12, 1992. Amsterdam: Kugler Publishers, 835-840.
16. Choufani G, Mahillon V, Decaestecker C, Lequeux T, Danguy A, Salmon I, Gabius HJ, Hassid S, and Kiss R (1999). Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Laryngoscope 109:1825-1831.
17. Cocchia D, Michetti F, and Donato R (1981). Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin. Nature 294:85-87.
18. Edelstein DR and Parisier SC (1989). Surgical techniques and recidivism in cholesteatoma. Otolaryngol Clin North Am 22:1029-1040.
19. Ehara H, Koji T, Deguchi T, Yoshii A, Nakano M, Nakane PK, and Kawada Y (1995). Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 27:304-313.
20. Fehrenbach H, Kasper M, Koslowski R, Pan T, Schuh D, Muller M, and Mason RJ (2000). Alveolar epithelial type II cell apoptosis in vivo during resolution of keratinocyte growth factor-induced hyperplasia in the rat. Histochem Cell Biol 114:49-61.
21. Finch PW and Cheng AL (1999). Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease. Gut 45:848-855.
22. Finch PW, Cunha GR, Rubin JS, Wong J, and Ron D (1995a). Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions. Dev Dyn 203:223-240.
23. Finch PW, Lengel C, and Chedid M (1995b). Cloning and characterization of the promoter region of the human keratinocyte growth factor gene. J Biol Chem 270:11230-11237.
24. Finch PW, Murphy F, Cardinale I, and Krueger JG (1997). Altered expression of keratinocyte growth factor and its receptor in psoriasis. Am J Pathol 151:1619-1628.
25. Finch PW, Rubin JS, Miki T, Ron D, and Aaronson SA (1989). Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245:752-755.
26. Fujioka O and Huang CC (1994). Platelet-derived growth factor in middle ear cholesteatoma. Eur Arch Otorhinolaryngol 251:199-204.
27. Fukuda Y, Ito Y, Azumi H, Edi NAS, Li ZL, Marumo M, Kasagawa O, and Otsuki Y (2002). Cell death and proliferation in Nd-YAG laser, electrocautery, and scalpel wounds on mice skin. J Derm Sci 28:106-118.
28. Gatter KC, Abdulaziz Z, Beverley P, Corvalan JR, Ford C, Lane EB, Mota M, Nash JR, Pulford K, Stein H, Taylor-Papadimitriou J, Woodhouse C, and Mason DY (1982). Use of monoclonal antibodies for the histopathological diagnosis of human malignancy. J Clin Pathol 35:1253-1267.
29. Giri D and Ittmann M (2000). Interleukin-1 alpha is a paracrine inducer of FGF7, a key epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 157:249-255.
30. Halaban R, Funasaka Y, Lee P, Rubin J, Ron D, and Birnbaum D (1991). Fibroblast growth factor in normal and malignant melanocytes. Ann NY Acad Sci 638:232-243.
31. Harker LA (1977). Cholesteatoma an evidence study. In: McCabe BF, Sade J, and Abramson M, editors. Cholesteatoma First International Conference. Birmingham: Aesculapius Publishers, 308-309.
32. Housley RM, Morris CF, Boyle W, Ring B, Biltz R, Tarpley JE, Aukerman SL, Devine PL, Whitehead RH, and Pierce GF (1994). Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 94:1764-1777.
33. Ishibashi T, Shinogami M, Kaga K, and Fukaya T (1997). Keratinocyte growth factor and receptor mRNA expression in cholesteatoma of the middle ear. Acta Otolaryngol 117:714-718.
34. Jameson J, Ugarte K, Chen N, Yachi P, Fuchs E, Boismenu R, and Havran WL (2002). A role for skin γδT cells in wound repair. Science 296:747-749.
35. Johnson DE, Lu J, Chen H, Werner S, and Williams LT (1991). The human fibroblast growth factor receptor genes: A common structural arrangement underlies the mechanisms for generating receptor forms that differ in their third immunoglobulin domain. Mol Cell Biol 11:4627-4634.
36. Kim HJ, Tinling SP, and Chole RA (2001). Expression patterns of cytokeratins in retraction pocket cholesteatomas. Laryngoscope 111:1032-1036.
37. Kim HJ, Tinling SP, and Chole RA (2002). Expression patterns of cytokeratins in cholesteatomas: Evidence of increased migration and proliferation. J Korean Med Sci 17:381-388.
38. Koji T and Brenner RM (1993). Localization of estrogen receptor messenger ribonucleic acid in rhesus monkey uterus by nonradioactive in situ hybridization with digoxigenin-labeled oligodeoxynucleotides. Endocrinology 132:382-392.
39. Koji T, Chedid M, Rubin JS, Salyden OD, Csaky KG, Aaronson SA, and Brenner RM (1994a). Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: Keratinocyte growth factor as a progestomedin. J Cell Biol 125:393-401.
40. Koji T, Kobayashi N, Nakanishi Y, Yoshii A, Hashimoto S, Shibata Y, Anjiki N, Yamamoto R, Ueda T, Kanazawa S, and Nakane PK (I 994b). Immunohistochemical localization of Fas antigen in paraffin sections with rabbit antibodies against human synthetic Fas peptides. Acta Histochem Cytochem 27:459-463.
41. Koji T and Nakane PK (1996). Recent advances in molecular histochemical techniques: In situ hybridization and south-western histochemistry. J Electron Microsc 45:119-127.
42. Kojima H, Matsuhisa K, Shiwa M, Kamide Y, Nakamura M, Ohno T, and Moriyama H (1996). Expression of messenger RNA for keratinocyte growth factor in human cholesteatoma. Arch Otolaryngol Head Neck Surg 122:157-160.
43. Kojima H, Shiwa M, Kamide Y, and Moriyama H (1994). Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma. Acta Otolaryngol 114:423-429.
44. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the hand of bacteriophage T4. Nature 227:680-685.
45. Lang S, Schilling V, Wollenberg B, Mack B, and Nerlich A (1997). Localization of transforming growth factor-beta-expressing cells and comparison with major extracellular components in aural cholesteatoma. Ann Otol Rhinol Laryngol 106:669-673.
46. LaRochelle WJ, Dirsch OR, Finch PW, Cheon HG, May M, Marchese C, Pierce JH, and Aaronson SA (1995). Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera. J Cell Biol 129:357-366.
47. Marchese C, Rubin JS, Ron D, Faggioni A, Torrisi MR, Messina A, Frati L, and Aaronson SA (1990). Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: Differentiation response distinguishes KGF from EGF family. J Cell Physiol 144:326-332.
48. Mason DY, Comans-Bitter WM, Cordell JL, Verhoeven MA, and van Dongen JJ (1990). Antibody L26 recognizes an intracellular epitope on the B-cell-associated CD20 antigen. Am J Pathol 136:1215-1222.
49. Mason IJ, Fuller-Pace F, Smith R, and Dickson C (1994). FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalization and epithelial-mesenchymal interaction. Mech Dev 45:15-30.
50. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AML, and Aaronson SA (1992). Determination of ligand-binding specificity by alternative splicing: Two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci U S A 89:246-250.
51. Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D, and Aaronson SA (1991). Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 251:72-75.
52. Moll R, Franke WW, Schiller DL, Geiger B, and Krepler R (1982). The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11-24.
53. Nakajima T, Watanabe S, Sato Y, Shimosato Y, Motoi M, and Lennert K (1982). S-100 protein in Langerhans cells, interdigitating reticulum cells and histiocytosis X cells. Gann 73:429-432.
54. Norton AJ, Ramsay AD, Smith SH, Beverley PC, and Isaacson PG (1986). Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues. J Clin Pathol 39:399-405.
55. Orr-Urtreger A, Bedford MT, Burakova T, Arman E, Zimmer Y, Yayon A, Givol D, and Lonai P (1993). Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR-2). Dev Biol 158:475-486.
56. Osborn M, Debus E, and Weber K (1984). Monoclonal antibodies specific for vimentin. Eur J Cell Biol 34:137-143.
57. Planz B, Aretz HT, Wang Q, Tabatabaei S, Kirley SD, Lin CW, and McDougal WS (1999). Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Prostate 41:233-242.
58. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, and Aaronson SA (1989). Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA 86:802-806.
59. Schilling V, Bujia J, Negri B, Schulz P, and Kastenbauer E (1991). Immunologically activated cells in aural cholesteatoma. Am J Otolaryngol 12:249-253.
60. Schilling V, Negri B, Bujia J, Schulz P, and Kastenbauer E (1992). Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol 13:350-355.
61. Schulz P, Bujia J, Holly A, Schilling V, and Kastenbauer E (1993). Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha. Am J Otol 14:82-87.
62. Sculerati N and Bluestone CD (1989). Pathogenesis of cholesteatoma. Otolaryngol Clin North Am 22:859-868.
63. Smith SH, Brown MH, Rowe D, Callard RE, and Beverley PC (1986). Functional subsets of human helper-inducer cells defined by a new monoclonal antibody, UCHL1. Immunology 58:63-70.
64. Smola H, Thiekotter G, and Fusenig NE (1993). Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 122:417-429.
65. Staiano-Coico L, Krueger JG, Rubin JS, D'Iimi S, Vallat VP, Valentino L, Fahey T, Hawes A, Kingston G, Madden MR, Mathwich M, Gottlieb AB, and Aaronson SA (1993). Human keratinocyte growth factor effects in a porcine model of wound healing. J Exp Med 178:865-878.
66. Sudhoff H, Bujia J, Fisseler-Eckhoff A, Holly A, Schulz-Flake C, and Hildmann H (1995). Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope 105:1227-1231.
67. Takasaka T, Houzawa K, Adachi M, Kawase T, Shiga N, Suzuki N, and Kobayashi T (1996). Pathogenesis of attic retractions and attic cholesteatomas. In: Sanna M, editor. Cholesteatoma and Mastoid Surgery Fifth International Conference, Rome, Italy, September 2-6. 1996. Rome: Cic Edizioni International, 296-300.
68. Terry LA, Brown MH, and Beverley PC (1988). The monoclonal antibody, UCHL1, recognizes a 180,000 MW component of the human leucocyte-common antigen, CD45. Immunology 64:331-336.
69. Tos M (1988). Incidence, etiology and pathogenesis of cholesteatoma in children. Adv Otorhinolaryngol 40:110-117.
70. Uyemura K, Deans RJ, Band H, Ohmen J, Panchamoorthy G, Morita CT, Rea TH, and Modlin RL (1991). Evidence for clonal selection of gamma/delta T cells in response to a human pathogen. J Exp Med 174:683-692.
71. Werner S, Peters KG, Longaker MT, Fuller-Pace F, Banda MJ, and Williams T (1992). Large induction of keratinocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci U S A 89:6896-6900.
72. Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH, and Williams LT (1994). The function of KGF in epithelial morphogenesis and reepithelization of wound. Science 266:819-822.
73. Wilson SE, Liang Q, and Kim WJ (1999). Lacrimal gland HGF, KGF and EGF mRNA levels increase after corneal epithelial wounding. Invest Ophthalmol Vis Sci 40:2185-2190.
74. Yan SD and Huang CC (1991). Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro. Ann Otol Rhinol Laryngol 100:157-161.
75. Yi ES, Williams ST, Lee H, Malicki DM, Chin EM, Yin S, Tarpley J, and Ulich TR (1996). Keratinocyte growth factor ameliorates radiation- and bleomycin-induced lung injury and mortality. Am J Pathol 149:1963-1970.
76. Yoshii A, Koji T, Ohsawa N, and Nakane PK (1995). In situ hybridization of ribosomal RNAs is a reliable reference for hybridizable RNA in tissue sections. J Histochem Cytochem 43:321-328.